The present invention provides quinoline derivatives of formula I that are PDE10A enzyme inhibitors, and as such are useful to treat neurodegenerative and psychiatric disorders. Especially, the invention provides compounds that are highly selective for PDE10 over other PDE subtypes. The present invention also provides pharmaceutical compositions comprising compounds of the invention and methods of treating disorders using the compounds of the invention.
本发明提供了式I的
喹啉衍
生物,它们是PDE10A酶
抑制剂,因此可用于治疗神经退行性和精神障碍。特别地,本发明提供了高度选择性作用于PDE10而非其他PDE亚型的化合物。本发明还提供了包含本发明化合物的制药组合物和使用本发明化合物治疗疾病的方法。